InsiderClue
Insiders · Profile

Kelly Thomas Patrick

Chief Financial Officer at Xenon Pharmaceuticals. Filing since 30 Sep 2026. CIK 0001410514

Company
Date
Role
Action
Shares
Amount
Of holding
XENE Xenon Pharmaceuticals Inc.
30 Sep 2026
Chief Financial Officer
Bought
15,000
$559.74K
opened
1 decision on file.